Video

Q&A With Jens Nielsen From Aarhus University Hospital: MANTRA-PAF Trial Results 5 Years Later for Paroxysmal Atrial Fibrillation Treatment

Author(s):

The MANTRA-PAF trial, A study looking at a treatment for paroxysmal atrial fibrillation reached its five year follow-up mark and the results were shared at the recent European Society of Cardiology Congress to see whether surgical or pharmaceutical treatment was better for patients.

The MANTRA-PAF trial, A study looking at a treatment for paroxysmal atrial fibrillation reached its five year follow-up mark and the results were shared at the recent European Society of Cardiology Congress to see whether surgical or pharmaceutical treatment was better for patients.

Jens Cosedis Nielsen, DMSc, PHD, from Aarhus University Hosptial discussed the results of the second round of follow ups during the European Society of Cardiology's annual conference in London. Nielsen said that while the results of the two treatment options were similar after 2 years, by the 5 year mar patients who had undergone the surgical option showed better results.

Related Videos
Understanding Angioedema in Urticaria, with Jonathan Bernstein, MD
Transformations in Aortic Disease Management with Mehrdad Ghoreishi, MD | Image Credit: Baptist Health South Florida
Caroline Piatek, MD: High HCRU, Patient Concerns Highlight Great Unmet Need in wAIHA
Steven W. Pipe, MD: Supporting Gene Therapy Implementation for Hemophilia
Corinna L. Schultz, MD: Improving Sickle Cell Trait Documentation in Infancy
Sibgha Zaheer, MD: Determining Washout Period With Fitusiran, Emicizumab Transition for Hemophilia
Pavan K. (Tem) Bendapudi, MD: Large-Scale Analyses Elucidate Genetic Risk of Thrombosis
Seema Rani, MD: Examining Sleep Health in Youth With SCD
Experts' Perspectives: Top Stories in Cardiology for 2024
Daniel Wang: A More Appropriate Ferritin Threshold is Cost-Effective for Iron Deficiency Screening
© 2025 MJH Life Sciences

All rights reserved.